CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,689,119 | +39.4% | 381,564 | +2.4% | 1.10% | +45.2% |
Q2 2023 | $4,080,233 | +47.8% | 372,624 | +17.7% | 0.76% | +39.5% |
Q1 2023 | $2,760,700 | -20.0% | 316,594 | -42.5% | 0.54% | -24.1% |
Q4 2022 | $3,451,447 | +190.3% | 550,470 | +62.0% | 0.71% | +176.7% |
Q3 2022 | $1,189,000 | -53.6% | 339,778 | -4.1% | 0.26% | -57.6% |
Q3 2020 | $2,565,000 | +98.7% | 354,337 | +268.4% | 0.61% | +198.0% |
Q2 2018 | $1,291,000 | -70.2% | 96,188 | -71.2% | 0.20% | -71.7% |
Q1 2018 | $4,335,000 | +8.6% | 333,737 | -23.1% | 0.72% | +1.0% |
Q4 2017 | $3,991,000 | -16.6% | 433,813 | -27.0% | 0.72% | +12.4% |
Q3 2017 | $4,788,000 | – | 594,004 | – | 0.64% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |